Latest updates for Novo Nordisk

Fresh curated links around Novo Nordisk are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Novo Nordisk India rolls-out once-weekly basal insulin Awiqli
  • Novo Nordisk pens long-acting GLP-1 implant tech deal with Vivani Medical
  • Novo Nordisk Flags Patient Data Breach From Some Clinical Trials in Cyberattack

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

thehindubusinessline.com /1 week ago

Novo Nordisk India rolls-out once-weekly basal insulin Awiqli

The product will be imported from Denmark and is priced at ₹2611 for a 1 ml pen (700 insulin units)

Read source
fiercebiotech.com /1 week ago

Novo Nordisk pens long-acting GLP-1 implant tech deal with Vivani Medical

As Novo Nordisk looks for new ways to broaden its semaglutide GLP-1 franchise, the Danish drugmaker has signed a new deal with Californian medtech Vivani Medical to help.

Read source
insurancejournal.com /1 month ago

Novo Nordisk Flags Patient Data Breach From Some Clinical Trials in Cyberattack

Novo Nordisk said on Thursday it has identified a security incident in which certain information, including patient data from some clinical trials, was copied externally without au...

Read source
seekingalpha.com /1 week ago

Novo Nordisk: Why I Don't Think The Story Is Broken

Read source
biopharmadive.com /1 month ago

CVS obesity drug deal puts Lilly on equal footing with Novo

The agreement includes Lilly’s new pill Foundayo and restores coverage for Zepbound, erasing what had been a commercial edge for rival Novo Nordisk. 

Read source
businesstoday.in /1 week ago

Novo Nordisk Launches Awiqli, World’s First Weekly Basal Insulin In India

Novo Nordisk has launched Awiqli (insulin icodec), the world’s first once-weekly basal insulin, in India. The company says the therapy could reduce the injection burden from 365 to...

Read source
thehindu.com /1 week ago

Shantha Biologics to provide cartridge fill-finish services for Novo Nordisk

Read source
pharmexec.com /1 month ago

<![CDATA[Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report ]]&g...

Read source
cafepharma.com /2 weeks ago

Management

Management Anonymous (not verified) Mon, 06/29/2026 - 03:04 field_thread_url https://cafepharma.com/boards/threads/management.710052/ bo...

Read source
cafepharma.com /1 week ago

Management

Management Anonymous (not verified) Sun, 07/05/2026 - 06:08 field_thread_url https://cafepharma.com/boards/threads/management.710052/ bo...

Read source
cafepharma.com /1 day ago

Novo hemorrhaging employees

Novo hemorrhaging employees Anonymous (not verified) Tue, 07/14/2026 - 12:15 field_thread_url https://cafepharma.com/boards/threads/novo-hemorrhaging-emplo...

Read source
fool.com /1 week ago

3 Reasons to Buy Novo Nordisk Stock

The stock is down, but it isn't out yet.

Read source
insurancejournal.com /4 weeks ago

Hacking Group Claims Major Hack of Novo Nordisk and Attempted $25M Extortion

A cyber extortion group claimed on Tuesday to have stolen more than a terabyte of data from pharmaceutical giant Novo Nordisk and said it is exploring selling parts of the data aft...

Read source
thehindubusinessline.com /1 month ago

Novo Nordisk launches higher-dose Wegovy for those seeking greater weightloss

Plans to file with the Indian regulator too, seeking approvals for the higher dose

Read source
globalnews.ca /1 month ago

Novo Nordisk will slash Ozempic price for some, ‘aligning’ with generics

Ozempic and Wegovy, both produced by Novo Nordisk, currently cost hundreds of dollars a month, depending on the dosage dispensed, in some cases more than $450.

Read source
insurancebusinessmag.com /4 weeks ago

Ozempic maker Novo Nordisk hit with $25 million ransom demand after claimed data breach

FulcrumSec says it spent more than two months inside Novo Nordisk's networks and is now exploring private sales of the data after the company refused to pay

Read source
insurancebusinessmag.com /4 weeks ago

Ozempic maker Novo Nordisk hit with $25 million ransom demand after claimed data breach

FulcrumSec says it spent more than two months inside Novo Nordisk's networks and is now exploring private sales of the data after the company refused to pay

Read source
blog.dubaicityguide.com /1 month ago

EDE Welcomes Novo Nordisk’s Decision To Establish UAE Pharmaceutical Distribution Hub

Novo Nordisk, the global pharmaceutical company and a leader in developing treatments for diabetes, obesity and rare diseases, has announced the establishment of a regional distrib...

Read source
scientificamerican.com /4 weeks ago

Ozempic maker Novo Nordisk breach exposed patients’ clinical trial data

Novo Nordisk said this security incident affected patient data, including health information and birth year

Read source
fiercebiotech.com /1 month ago

Novo reports data breach, tells clinical trial patients to 'remain vigilant'

As cybersecurity threats have proliferated across industries in recent years, biopharma companies have emerged as prominent targets, with intellectual property, patient data and ot...

Read source
fiercebiotech.com /1 month ago

‘I’m a lot more optimistic today’: Mike Doustdar tells Fierce about pivotal first year as Novo Nordisk CEO

Novo Nordisk CEO Mike Doustdar told Fierce in an interview that he always believed the Big Pharma “did actually need to become more competitive.”

Read source
japantimes.co.jp /4 weeks ago

Hacking group claims major attack of Novo Nordisk and attempted $25 million extortion

FulcrumSec, a cyber extortion group that emerged in October 2025, has said in a message ‌posted online that it spent more than two months in Novo Nordisk's ​networks stealing data.

Read source
valueresearchonline.com /1 month ago

The blockbuster drug India can now actually afford

With Novo Nordisk's patent gone in India, a dozen generics have flooded in at a fraction of the price, and a market of 10 crore diabetics is waiting

Read source
law360.com /3 weeks ago

Wholesalers Say Novo Can't Duck GLP-1 Antitrust Suits

Drug buyers want a New York federal judge to preserve proposed class claims accusing Novo Nordisk of paying Teva to delay generic competition with its Victoza GLP-1 drug, arguing t...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Novo Nordisk

blog.dubaicityguide.com

Recent coverage from public sources
Public source

rss.sciam.com

Recent coverage from public sources
Public source

cafepharma.com

Recent coverage from public sources
Public source

globalnews.ca

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

biopharmadive.com

Recent coverage from public sources
Public source